- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Avapro
Synonyms :
Class :
Angiotensin receptor blockers
Dosage Forms & Strengths
Tablet
75mg
150mg
300mg
Dosage Forms & Strengths
Tablet
75mg
150mg
300mg
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
may increase the hyperkalemic effect of aliskiren
may increase the adverse effect of angiotensin II receptor blockers
may enhance the serum concentration of angiotensin II receptor blockers
may increase the hyperkalemic effect of aliskiren
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents
may diminish the therapeutic effect of angiotensin II Receptor Blockers
may diminish the therapeutic effect of angiotensin II Receptor Blockers
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
angiotensin II Receptor Blockers may enhance the hyperkalemic effect of potassium-Sparing Diuretics
angiotensin II Receptor Blockers may enhance the hyperkalemic effect of potassium-Sparing Diuretics
angiotensin II Receptor Blockers may enhance the hyperkalemic effect of finerenone
it increases the effect of hyperkalemia of angiotensin II receptor blockers
it increases the hypotensive effect of angiotensin II receptor blockers
it increases the hypotensive effect of angiotensin II receptor blockers
it increases the hypotensive effect of angiotensin II receptor blockers
it increases the effect of hyperkalemia of angiotensin II receptor blockers
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
it increases the toxicity of angiotensin II receptor blockers
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
may increase the toxic effect of non-steroidal anti-inflammatory drugs
may enhance the hypotensive effect of angiotensin II receptor antagonist
may enhance the hypotensive effect of angiotensin II receptor antagonist
may enhance the hypotensive effect of angiotensin II receptor antagonist
may decrease the therapeutic effect of angiotensin-converting enzyme inhibitors
may decreases the therapeutic effect. Angiotensin receptor
may increase the toxic effect of nonsteroidal anti-inflammatory agents
may increase the hyperkalemic effect when combined with angiotensin II receptor blockers
drospirenone/ethinyl estradiol/levomefolate
may increase the hyperkalemic effect of Drospirenone-Containing Products
Adverse drug reactions:
Frequency Defined
>10%
Hyperkalemia (19%)
1-10%
Dizziness (10%)
Fatigue (4%)
Diarrhea (3%)
Orthostatic hypotension (5%)
Dyspepsia (2%)
Upper respiratory tract infection (9%)
Post marketing Reports
Urticaria
angioedema
elevated liver function test results
Jaundice
Hepatitis
Hyperkalemia
Thrombocytopenia
Pregnancy warnings:
AU TGA pregnancy category: D
US FDA pregnancy category: Not assigned. Lactation:
Excreted into human milk is Unknown
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: irbesartan
Why do we use irbesartan?
irbesartan is an Angiotensin receptor blocker which is used to treat hypertension and diabetic nephropathy.